Sliman Joseph A. 4
4 · Synthetic Biologics, Inc. · Filed Dec 21, 2017
Insider Transaction Report
Form 4
Sliman Joseph A.
Chief Medical Officer
Transactions
- Award
Stock Options
2017-12-20+410,000→ 410,000 totalExercise: $0.52From: 2017-12-20Exp: 2024-12-19→ Common Stock (410,000 underlying)
Footnotes (1)
- [F1]These options will vest monthly on a pro rata basis over 36 consecutive months.